Antibody provider Atlas Antibodies acquires antibody expression servicer evitria

Primary antibodies manufacturer and provider Atlas Antibodies (Stockholm, Sweden) has acquired evitria (Zurich, Switzerland), a provider of recombinant antibody expression in Chinese hamster ovary cells. It is hoped that the acquisition will serve Atlas Antibodies’ existing audience base with a provider of highly validated research antibodies and custom recombinant antibody expression. Founded in 2010, evitria focuses on Chinese hamster ovary-based transient expression of antibodies and other proteins and offer full outsourcing of antibody production for research. The company has performed over 75,000 transfections and purified more than 12,000 antibody-based molecules. Christian Eberle, CEO of evitria, commented: “After successfully building and...